Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/TORII-PHARMACEUTICAL-CO-L-6493868/news/Torii-Pharmaceutical-Co-Ltd-kundigt-den-Beginn-einer-Phase-3-Studie-mit-VP-102-zur-Behandlung-von-41166444/?utm_source=whatsapp&utm_medium=social&utm_campaign=share